Biophotovoltaics as Indonesia’s Third-Generation Bet
BRIN‘s Research Centre for Nanotechnology Systems is leading work on bio-photovoltaic solar cells based on the purple bacterium Rhodobacter sphaeroides, according to a report citing Indonesia’s state news agency ANTARA. Researchers extract the reaction centre–light-harvesting 1 (RC-LH1) protein complex from the bacteria and deploy it as the core light-absorbing component. They then combine this biological layer with semiconductor materials to create charge separation when exposed to sunlight, enabling direct conversion of solar energy into electrical power.
The prototype device uses a layered electrode structure. On the cathode side, the team stacks indium tin oxide, zinc oxide and fullerene. The anode side uses molybdenum oxide and silver. This architecture aims to increase the efficiency with which the device collects charges generated by the bacterial photosystems. Researchers report that the prototype delivers a notably high open-circuit voltage for a solid-state biophotovoltaic system, marking a technical milestone for this niche segment of solar research.
Scientists involved in the project classify the approach as a third-generation solar cell technology. They highlight the sustainability advantages: purple bacteria are non-pathogenic and possess highly efficient photosynthetic machinery. The cell stack uses relatively low-toxicity, environmentally friendlier materials that can be processed at lower temperatures. The biological feedstock is also abundant, positioning the concept as a potential route to more sustainable solar materials if performance scales beyond the lab.
Early-Stage Deep Tech with Downstream Manufacturing Potential
For now, the purple bacteria solar work sits firmly at the prototype stage. However, it signals that Indonesia’s innovation system is moving beyond deployment of imported panels into upstream deep-tech research around solar materials and device physics. BRIN, formed through the consolidation of Indonesia’s research bodies earlier in the decade, has a mandate to link such projects more tightly with industrial partners and long-term technology roadmaps.
By integrating biological photosystems with established semiconductor platforms, the project opens several possible paths for investors. Over time, proprietary know-how around RC-LH1 extraction, stabilisation, and device integration could translate into local intellectual property in bio-based photovoltaics. That IP could support licensing opportunities, joint ventures with module manufacturers, or the creation of specialist production lines for bio-hybrid solar components.
The materials stack in the prototype — indium tin oxide, zinc oxide, fullerene, molybdenum oxide and silver — aligns with existing thin-film and organic photovoltaic processes. This raises the prospect that any successful design could plug into, or modestly adapt, conventional fabrication workflows rather than require entirely new industrial infrastructure. For Indonesia, which is working to raise its share of value added in the global solar supply chain, that compatibility matters.
The research also dovetails with the country’s broader push to expand renewable generation and nurture higher-value manufacturing. Although these biophotovoltaic cells are unlikely to influence utility-scale deployment in the near term, they point to a widening technology pipeline that can underpin more sophisticated domestic capabilities over the next decade.
For investors, the signal is clear rather than immediate: Indonesia is beginning to back frontier energy research that could, with time and consistent funding, feed into local high-value manufacturing niches. The next markers to watch will be follow-on funding rounds, patent filings around bacterial photosystems in solar devices, and any moves by regional manufacturers to partner with BRIN on scaling purple bacteria solar beyond the laboratory.
